ketamine has been researched along with Brittle Bone Disease in 2 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Libman, RH | 1 |
| Oliverio, RM | 1 |
2 other studies available for ketamine and Brittle Bone Disease
| Article | Year |
|---|---|
Anesthetic considerations for the patient with osteogenesis imperfecta.
Topics: Anesthesia, General; Humans; Ketamine; Osteogenesis Imperfecta | 1981 |
Anesthetic management of intramedullary nailing in osteogenesis imperfecta: report of a case.
Topics: Anesthesia, General; Child, Preschool; Fracture Fixation, Intramedullary; Humans; Injections, Intram | 1973 |